Red wine but not alcohol consumption improves cardiovascular function and oxidative stress of the hypertensive-SHR and diabetic-STZ rats

References

• Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–29. doi:10.1038/nrm1155.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Calcium microdomains: organization and function. Cell Calcium. 2006;40(5–6):405–12. doi:10.1016/j.ceca.2006.09.002.
   PubMed Web of Science ®Google Scholar
• Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415(6868):198–205. doi:10.1038/415198a.
   PubMed Web of Science ®Google Scholar
• Chahoud J, Mrad J, Semaan A, Asmar R. Prevalence of diabetes mellitus among patients with essential arterial hypertensiON. J Med Liban. 2015;63(2):74–80. doi:10.12816/0012554.
   PubMedGoogle Scholar
• Gohardehi F, Seyedin H, Moslehi S. Prevalence rate of diabetes and hypertension in disaster-exposed populations: a systematic review and meta-analysis. Ethiop J Health Sci. 2020;30(3):439–48. doi:10.4314/ejhs.v30i3.15.
   PubMedGoogle Scholar
• Gomes CS, Bernal RTI, Moreira AD, Teixeira RA, Cardoso LSM, Ribeiro ALP, et al. Estimates of hypertension and diabetes mellitus prevalence according to Health vulnerability index in belo horizonte, MG, Brazil. Rev Bras Epidemiol. 2021;24(1):e210015. doi:10.1590/1980-549720210015.supl.1.
   PubMedGoogle Scholar
• Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23. doi:10.1016/S0140-6736(05)17741-1.
   PubMed Web of Science ®Google Scholar
• Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens. 2004;26(7–8):621–28. doi:10.1081/CEH-200031945.
   PubMed Web of Science ®Google Scholar
• Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989;14(2):177–83. doi:10.1161/01.HYP.14.2.177.
   PubMed Web of Science ®Google Scholar
• de Champlain J, Farley L, Cousineau D, van Ameringen MR. Circulating catecholamine levels in human and experimental hypertension. Circ Res. 1976;38(2):109–14. doi:10.1161/01.RES.38.2.109.
   PubMedGoogle Scholar
• Donohue SJ, Stitzel RE, Head RJ. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther. 1988;245(1):24–31.
   PubMedGoogle Scholar
• Musial DC, Bomfim GH, Arranz-Tagarro JA, Mendez-Lopez I, Miranda-Ferreira R, Jurkiewicz A, Jurkiewicz NH, García AG, Padín JF, et al. Altered mitochondrial function, calcium signaling, and catecholamine release in chromaffin cells of diabetic and SHR rats. Eur J Pharmacol. 2017;815:416–26.
   PubMedGoogle Scholar
• Konukoglu D, Uzun H. Endothelial dysfunction and hypertension. Adv Exp Med Biol. 2017;956:511–40.
   PubMed Web of Science ®Google Scholar
• Lv Q, Wang Y, Li Y, Zhao L, Gong Y, Wang M, Wang M, Fu G, Zhang W, et al. Rosuvastatin reverses hypertension-induced changes in the aorta structure and endothelium-dependent relaxation in rats through suppression of apoptosis and inflammation. J Cardiovasc Pharmacol. 2020;75(6):584–95. doi:10.1097/FJC.0000000000000828.
   PubMedGoogle Scholar
• Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension. Curr Hypertens Rev. 2020;16(3):166–80. doi:10.2174/1573402115666190531071924.
   PubMedGoogle Scholar
• Sinha N, Dabla PK. Oxidative stress and antioxidants in hypertension-a current review. Curr Hypertens Rev. 2015;11(2):132–42. doi:10.2174/1573402111666150529130922.
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Balatbat CA. Future of hypertension. Hypertension. 2019;74(3):450–57. doi:10.1161/HYPERTENSIONAHA.119.13437.
   PubMed Web of Science ®Google Scholar
• Esler M. The sympathetic nervous system in hypertension: back to the future?. Curr Hypertens Rep. 2015;17(2):11. doi:10.1007/s11906-014-0519-8.
   PubMedGoogle Scholar
• Morrison SF, Whitehorn D. Enhanced preganglionic sympathetic nerve responses in spontaneously hypertensive rats. Brain Res. 1984;296(1):152–55. doi:10.1016/0006-8993(84)90522-5.
   PubMedGoogle Scholar
• Bomfim GHS, Musial DC, Miranda-Ferreira R, Nascimento SR, Jurkiewicz A, Jurkiewicz NH, de Moura RS, et al. Antihypertensive effects of the vitis vinifera grape skin (ACH09) extract consumption elicited by functional improvement of P1 (A1) and P2 (P2X1) purinergic receptors in diabetic and hypertensive rats. PharmaNutrition. 2019;8:100146.
   Web of Science ®Google Scholar
• Bertelli AA. Wine, research and cardiovascular disease: instructions for use. Atherosclerosis. 2007;195(2):242–47. doi:10.1016/j.atherosclerosis.2007.04.006.
   PubMed Web of Science ®Google Scholar
• Orallo F, Alvarez E, Camiña M, Leiro JM, Gómez E, Fernández P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002;61(2):294–302. doi:10.1124/mol.61.2.294.
   PubMedGoogle Scholar
• Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523–26. doi:10.1016/0140-6736(92)91277-F.
   PubMed Web of Science ®Google Scholar
• Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AFG. Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr. 2019;59(10):1605–18. doi:10.1080/10408398.2017.1422480.
   PubMed Web of Science ®Google Scholar
• Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem. 2006;13(1):87–98. doi:10.2174/092986706775197962.
   PubMed Web of Science ®Google Scholar
• Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. Int J Hypertens. 2017;2017:5491838. doi:10.1155/2017/5491838.
   PubMed Web of Science ®Google Scholar
• O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: the dose makes the poison … or the remedy. Mayo Clin Proc. 2014;89(3):382–93. doi:10.1016/j.mayocp.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Y, Li S, Lichtenstein AH, Chen S, Na M, Veldheer S, Xing A, Wang Y, Wu S, et al. Alcohol consumption and risk of cardiovascular disease, cancer and mortality: a prospective cohort study. Nutr J. 2021;20(1):13. doi:10.1186/s12937-021-00671-y.
   PubMed Web of Science ®Google Scholar
• Bomfim GHS, Mendez-Lopez I, Fernandez-Morales JC, Padin JF, Jurkiewicz A, Jurkiewicz NH, García AG, et al. Electrophysiological properties and augmented catecholamine release from chromaffin cells of WKY and SHR rats contributing to the hypertension development elicited by chronic EtOH consumption. Eur J Pharmacol. 2017;803:65–77.
   PubMedGoogle Scholar
• Musial DC, Bomfim GH, Miranda-Ferreira R, Caricati-Neto A, Jurkiewicz A, Jurkiewicz NH. Chronic treatment with red wine modulates the purinergic neurotransmission and decreases blood pressure in hypertensive SHR and diabetic-STZ rats. Int J Food Sci Nutr. 2015;66(5):579–86. doi:10.3109/09637486.2015.1056110.
   PubMed Web of Science ®Google Scholar
• Lassègue B, Griendling KK. Reactive oxygen species in hypertension; an update. Am J Hypertens. 2004;17(9):852–60. doi:10.1016/j.amjhyper.2004.02.004.
   PubMed Web of Science ®Google Scholar
• Musial DC, de Magalhães Galvão K, Miranda-Ferreira R, Dantas da Silva Júnior E, Caricati-Neto A, Jurkiewicz NH, Jurkiewicz A, Broetto Biazon AC, et al. Alteration of purinergic neurotransmission in isolated atria of streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol. 2012;59(2):158–64. doi:10.1097/FJC.0b013e31823a0f31.
   PubMedGoogle Scholar
• Musial DC, Bomfim GH, Arranz-Tagarro JA, Méndez-López I, Miranda-Ferreira R, Jurkiewicz A, Jurkiewicz NH, García AG, Padín JF, et al. Altered mitochondrial function, calcium signaling, and catecholamine release in chromaffin cells of diabetic and SHR rats. Eur J Pharmacol. 2017;815:416–26.
   PubMedGoogle Scholar
• Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000;43(12):1528–33. doi:10.1007/s001250051564.
   PubMed Web of Science ®Google Scholar
• Caillaud K, Boisseau N, Ennequin G, Chavanelle V, Etienne M, Li X, Denis P, Dardevet D, Lacampagne A, Sirvent P, et al. Neuregulin 1 improves glucose tolerance in adult and old rats. Diabetes Metab. 2016;42(2):96–104. doi:10.1016/j.diabet.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L. Blood glucose area under the curve. Methodol Aspects Diabetes Care. 1990;13(2):172–75. doi:10.2337/diacare.13.2.172.
   PubMed Web of Science ®Google Scholar
• Fanzone M, Peña-Neira A, Jofré V, Assof M, Zamora F. Phenolic characterization of malbec wines from mendoza province (Argentina). J Agric Food Chem. 2010;58(4):2388–97. doi:10.1021/jf903690v.
   PubMedGoogle Scholar
• Bomfim GHS, Musial DC, Méndez-López I, Jurkiewicz A, Jurkiewicz NH, Padín JF, García AG, et al. Chronic resveratrol consumption prevents hypertension development altering electrophysiological currents and Ca(2+) signaling in chromaffin cells from SHR rats. Cell Signal. 2020;76:109811.
   PubMedGoogle Scholar
• Souza Bomfim GH, Mendez-Lopez I, Arranz-Tagarro JA, Ferraz Carbonel AA, Roman-Campos D, Padín JF, et al. Functional upregulation of STIM-1/Orai-1-Mediated store-operated Ca2+ contributing to the hypertension development elicited by chronic EtOH consumption. Curr Vasc Pharmacol. 2017;15(3):265–81. doi:10.2174/1570161115666170201122750.
   PubMedGoogle Scholar
• Wilson C, Lee MD, McCarron JG. Acetylcholine released by endothelial cells facilitates flow-mediated dilatation. J Physiol. 2016;594(24):7267–307. doi:10.1113/JP272927.
   PubMed Web of Science ®Google Scholar
• Do KH, Kim MS, Kim JH, Rhim BY, Lee WS, Kim CD, Bae SS, et al. Angiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway. Exp Mol Med. 2009;41(8):569–76. doi:10.3858/emm.2009.41.8.062.
   PubMedGoogle Scholar
• Doggrell SA. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats. J Pharm Pharmacol. 2002;54(10):1407–12. doi:10.1211/002235702760345509.
   PubMedGoogle Scholar
• Jiang ZY, Woollard AC, Wolff SP. Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids. 1991;26(10):853–56. doi:10.1007/BF02536169.
   PubMed Web of Science ®Google Scholar
• Ferro Cde O, Chagas VL, de Oliveira Mf, de Oliveira Pl, Schanaider A, de Oliveira MF, de Oliveira PL. Catalase activity in lung, kidney and small bowel non-ischemic in rats after intestinal reperfusion. Rev Col Bras Cir. 2010;37(1):31–38. doi:10.1590/s0100-69912010000100008.
   PubMedGoogle Scholar
• Friedman J, Peleg E, Kagan T, Shnizer S, Rosenthal T. Oxidative stress in hypertensive,diabetic, and diabetic hypertensive rats. Am J Hypertens. 2003;16(12):1049–52. doi:10.1016/j.amjhyper.2003.07.013.
   PubMedGoogle Scholar
• Szmitko PE, Verma S. Cardiology patient pages. Red wine and your heart. Circulation. 2005;111(2):e10–1. doi:10.1161/01.CIR.0000151608.29217.62.
   PubMedGoogle Scholar
• Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2009;22(3):169–88. doi:10.1111/j.1527-3466.2004.tb00139.x.
   Google Scholar
• Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int J Mol Sci. 2019;20(7):1523. doi:10.3390/ijms20071523.
   PubMed Web of Science ®Google Scholar
• Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int J Mol Med. 2001;8(1):3–17. doi:10.3892/ijmm.8.1.3.
   PubMedGoogle Scholar
• Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006;290(6):E1339–46. doi:10.1152/ajpendo.00487.2005.
   PubMed Web of Science ®Google Scholar
• López-Fernández-Sobrino R, Soliz-Rueda JR, Ávila-Román J, Arola-Arnal A, Suárez M, Muguerza B, et al. Blood Pressure-lowering effect of wine lees phenolic compounds is mediated by endothelial-derived factors: role of sirtuin 1. Antioxid. 2021;10(7).
   Google Scholar
• Idris Khodja N, Chataigneau T, Auger C, Schini-Kerth VB. Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system. PLoS One. 2012;7(2):e32039. doi:10.1371/journal.pone.0032039.
   PubMedGoogle Scholar
• Cishek MB, Galloway MT, Karim M, German JB, Kappagoda CT. Effect of red wine on endothelium-dependent relaxation in rabbits. Clin Sci (Lond). 1997;93(6):507–11. doi:10.1042/cs0930507.
   PubMed Web of Science ®Google Scholar
• Zenebe W, Pechánová O, Andriantsitohaina R. Red wine polyphenols induce vasorelaxation by increased nitric oxide bioactivity. Physiol Res. 2003;52(4):425–32.
   PubMedGoogle Scholar
• Alhosin M, Anselm E, Rashid S, Kim JH, Madeira SV, Bronner C, Schini-Kerth VB, et al. Redox-sensitive up-regulation of eNOS by purple grape juice in endothelial cells: role of PI3-kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a. PLoS One. 2013;8(3):e57883. doi:10.1371/journal.pone.0057883.
   PubMed Web of Science ®Google Scholar
• Anselm E, Chataigneau M, Ndiaye M, Chataigneau T, Schini-Kerth VB. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of eNOS. Cardiovasc Res. 2007;73(2):404–13. doi:10.1016/j.cardiores.2006.08.004.
   PubMed Web of Science ®Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84. doi:10.1016/j.cjca.2017.12.005.
   PubMed Web of Science ®Google Scholar
• Kotchen TA, Guthrie GP. Renin-angiotensin-aldosterone and hypertension. Endocr Rev. 1980;1(1):78–99. doi:10.1210/edrv-1-1-78.
   PubMedGoogle Scholar
• Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens. 2005;14(2):125–31. doi:10.1097/00041552-200503000-00007.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Tsounapi P, Honda M, Dimitriadis F, Taniuchi K, Shimizu T, et al. Effect of an angiotensin II receptor blocker and a calcium channel blocker on hypertension associated penile dysfunction in a rat model. Biomed Res. 2014;35(3):215–21. doi:10.2220/biomedres.35.215.
   PubMedGoogle Scholar
• Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res. 2006;71(4):794–802. doi:10.1016/j.cardiores.2006.05.022.
   PubMed Web of Science ®Google Scholar
• Inanaga K, Ichiki T, Matsuura H, Miyazaki R, Hashimoto T, Takeda K, Sunagawa K, et al. Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertens Res. 2009;32(6):466–71. doi:10.1038/hr.2009.47.
   PubMedGoogle Scholar
• Rodrigo R, Gil D, Miranda-Merchak A, Kalantzidis G. Antihypertensive role of polyphenols. Adv Clin Chem. 2012;58:225–54.
   PubMed Web of Science ®Google Scholar
• Guyton AC. The relationship of cardiac output and arterial pressure control. Circulation. 1981;64(6):1079–88. doi:10.1161/01.CIR.64.6.1079.
   PubMedGoogle Scholar
• Dornas WC, Cardoso LM, Silva M, Machado NL, Chianca DA, Alzamora AC, Lima WG, Lagente V, Silva ME, et al. Oxidative stress causes hypertension and activation of nuclear factor-κB after high-fructose and salt treatments. Sci Rep. 2017;7(1):46051. doi:10.1038/srep46051.
   PubMedGoogle Scholar
• Chia TY, Murugaiyah V, Khan NA, Sattar MA, Abdulla MH, Johns EJ, Ahmad A, Hassan Z, Kaur G, Mei H, et al. Inhibition of L-NAME-induced hypertension by combined treatment with apocynin and catalase: the role of Nox 4 expression. Physiol Res. 2021;70(1):13–26. doi:10.33549/physiolres.934497.
   PubMedGoogle Scholar
• Unudurthi SD, Wolf RM, Hund TJ. Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol. 2014;5:446. doi:10.3389/fphys.2014.00446.
   PubMedGoogle Scholar
• Pignatelli P, Menichelli D, Pastori D, Violi F. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018;76(4):713–22. doi:10.5603/KP.a2018.0071.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Heck NV, Ferreira I, Göethel G, Somacal S, Emanuelli T, Rodrigues E, Garcia SC, Welke JE, Augusti PR, et al. Ochratoxin A presence in cabernet sauvignon wine changes antioxidant activity in vitro and oxidative stress markers in vivo. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020;37(10):1755–64. doi:10.1080/19440049.2020.1802067.
   PubMedGoogle Scholar
• Liu FC, Tsai HI, Yu HP. Organ-Protective effects of red wine extract, resveratrol, in oxidative stress-mediated reperfusion injury. Oxid Med Cell Longev. 2015;2015:568634. doi:10.1155/2015/568634.
   PubMedGoogle Scholar
• Schrieks IC, van den Berg R, Sierksma A, Beulens JW, Vaes WH, Hendriks HF. Effect of red wine consumption on biomarkers of oxidative stress. Alcohol Alcohol. 2013;48(2):153–59. doi:10.1093/alcalc/ags086.
   PubMedGoogle Scholar
• Pignatelli P, Ghiselli A, Buchetti B, Carnevale R, Natella F, Germanò G, Fimognari F, Di Santo S, Lenti L, Violi F, et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis. 2006;188(1):77–83. doi:10.1016/j.atherosclerosis.2005.10.025.
   PubMedGoogle Scholar